BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment ...

Lundbeck’ amlenetug receives Japanese orphan drug designation for treatment of multiple system atrophy: Denmark Tuesday, March 11, 2025, 11:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...

Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, today announced that it has secured ?9.

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.

The Honorable M. Casey Rodgers and Magistrate Judge Hope T. Cannon of the United States District Court for the Northern ...

Donna is survived by her three sons, Craig (Kim) of Atlanta, David (Cheryl) and Michael (Karan) of Ringgold, seven ...

REM sleep behavior disorder is characterized by acting out dreams, which may include shouting, kicking and punching during sleep.

The 22nd Annual CurePSP Awareness and Memorial Walk will take place on March 29th at Mackle Park on Marco Island. The event ...

We recently published a list of 10 Best Australian Stocks to Buy According to Billionaires. In this article, we are going to ...

The class is one in a series supporting the Redbud Writing Project’s mission to make creative writing accessible.